Stephen Tsang, MD, PhD, reviews promising optogenetic therapy results for retinitis pigmentosa and Stargardt disease, enhancing vision and mobility for patients.
Stephen Tsang, MD, PhD
Advertisement
Articles by Stephen Tsang, MD, PhD
Advertisement
Latest Updated Articles
Q&A: Stephen Tsang discusses outcomes in retinitis pigmentosa and Stargardt trialsPublished: November 13th 2025 | Updated:
Advertisement
Advertisement
Trending on Modern Retina
1
The gene therapy shift: A closer look at the science powering next-generation retinal treatments
2
Understanding fluid fluctuation in retinal disorders
3
Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA
4
Evaluating Progressive Multifocal Geographic Atrophy in an Asymptomatic 81-Year-Old Male
5
